Indivior Pharmaceuticals, Inc. Common Stock (INDV) Earnings

INDV Earnings Reports

Positive Surprise Ratio

INDV beat 15 of 22 last estimates.

68%

Next Report

Tomorrow BMO

Date of Next Report

Oct 29, 2026

Estimate for Q3 26 (Revenue/ EPS)

$335.94M

$1.14

Implied change from Q2 26 (Revenue/ EPS)

-2.06%

Implied change from Q3 25 (Revenue/ EPS)

+6.99%

+58.33%

Indivior Pharmaceuticals, Inc. Common Stock earnings per share and revenue

On Aug 03, 2026, INDV reported earnings of 1.14 USD per share (EPS) for Q2 26, beating the estimate of 0.89 USD, resulting in a 28.97% surprise. Revenue reached 343.00 million, compared to an expected 313.70 million, with a 9.34% difference. The market reacted with a -2.33% price change (close before vs. close after earnings).

Looking ahead to Q3 26, 5 analysts forecast an EPS of 1.14 USD, with revenue projected to reach 335.94 million USD, implying an increase of 0.00% EPS, and decrease of -2.06% in Revenue from the last quarter.

FAQ

What were Indivior Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Indivior Pharmaceuticals, Inc. Common Stock reported EPS of $1.14, beating estimates by 28.97%, and revenue of $343.00M, 9.34% above expectations.

How did the market react to Indivior Pharmaceuticals, Inc. Common Stock's Q2 2026 earnings?

The stock price moved down -2.33%, changed from $37.37 before the earnings release to $36.50 the day after.

When is Indivior Pharmaceuticals, Inc. Common Stock expected to report next?

The next earning report is scheduled for Oct 29, 2026.

What are the forecasts for Indivior Pharmaceuticals, Inc. Common Stock's next earnings report?

Based on 5 analysts, Indivior Pharmaceuticals, Inc. Common Stock is expected to report EPS of $1.14 and revenue of $335.94M for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.